These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 14755628)
1. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628 [TBL] [Abstract][Full Text] [Related]
2. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment. Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599 [TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine output is compromised within +/- BDNF mice. Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489 [TBL] [Abstract][Full Text] [Related]
4. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Ryoo HL; Pierrotti D; Joyce JN Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147 [TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
7. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
8. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. Itzhak Y; Gandia C; Huang PL; Ali SF J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865 [TBL] [Abstract][Full Text] [Related]
9. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53. Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780 [TBL] [Abstract][Full Text] [Related]
10. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice. Dluzen DE Neurosci Lett; 2004 Apr; 359(3):135-8. PubMed ID: 15050682 [TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736 [TBL] [Abstract][Full Text] [Related]